'One can only hope and pray that those who ended up taking the placebo will be able to survive to see Rem-L get approved and then receive and experience the treatment first hand.'
Unfortunately the opposite would need to be true, which is, that those taking the placebo would need to suffer high casualty rates for the trial to be successful and Rem-L to be approved.
Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-153
-
- There are more pages in this discussion • 293 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 29390 | 93.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 14089 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |